CME Online
The newest CME presentations
are at the top of this page.
Those nearing expiration are nearer the bottom of the page.
|
What’s New In Hypertension Since The
JNC 7 Guidelines |
|
|
Practical Application of Insulin Pump
Therapy
In Type 2 Diabetes |
History, Injury and Blood Flow: The
Keys to Detection of Venous Thromboembolism Deep Vein Thrombosis alone occurs in about 2 million Americans each year, accounting for up to 600,000 DVT hospitalizations. Pulmonary Embolism (PE) accounts for nearly 300,000 deaths per year, with the majority of those occurring from the onset of DVT. Together, Venous Thromboembolism (VTE) occurs in about 600,000 cases per year, with a large portion of those cases being diagnosed upon conclusion of an autopsy. The key to preventing DVT, PE and ultimately VTE is early recognition and diagnosis, along with preventative methods for patients at higher risk to adhere to CME Valid to December 31, 2010 |
|
Osteoporosis: Decreasing Costs by
Improving Prevention,
Early Diagnosis & Patient Outcomes Osteoporosis is preventable, but it is not curable, only treatable. It is important that doctors stay aware of the risk factors, and perform bone mineral density (BMD) tests for diagnosis for high-risk patients. Medicare reimburses BMD testing every two years. Fractures from osteoporosis reduce a patient’s quality of life and an average of 24% of hip fracture patients aged 50 and up die in the year following their fracture. The importance of prevention and early diagnosis is apparent and of utmost importance to managed care medical directors, case managers and administrators. CME Valid to December 31, 2010 |
Effective Diagnosis and Treatmentof Early Parkinson’s Disease The session will provide important insights into effective management, including diagnosis and treatment of early PD. This educational activity will help attendees identify patients in need of early treatment and to distinguish disease progression from suboptimal treatment outcomes with the goal of improving patient care. It is imperative that Managed Care Medical Directors, Neurologists, Nurses and Healthcare Executives, who will be present at the Fall Managed Care Forum, learn about these advances in treatment and how to integrate them into their respective plan or provider organizations. CME Valid to December 31, 2010 |
|
Inattention, Hyperactivity and
Impulsivity: The Diagnosis, Management and Treatment of Behavioral Deficits Attributed to ADHD Attention-Deficit/Hyperactivity Disorder (ADHD) is a developmental disorder, comprised of deficits in behavioral inhibition, staying focused, resisting distractions and ability to regulate one’s activity level to the appropriate situation. While inattention, hyperactivity and impulsivity are typical behaviors exuded during childhood, for those with ADHD, these behaviors are much more severe and occur more often. With the increasing number of ADHD diagnoses and additional problems that can be associated with it, Attention-Deficit/Hyperactivity Disorder has a huge impact, economically. In 2005, the ‘cost of illness’ (not total impact) for ADHD was estimated to be anywhere from $36 billion to $52 billion, or between $12,005 and $17,458 annually per individual. Comparatively, previous statistics show that in 2000, total excess cost of ADHD in the US was $31.6 billion, an increase of at least $4 billion in just a five-year period. Work loss, though not built into this figure, also creates a significant financial burden on society and in a study of 10 different countries worldwide, the employer ‘cost’ associated with ADHD is 143.8 million days lost of work productivity annually. CME Valid to December 31, 2010 |
Evolving Concepts in CVD Risk Assessment: Implications in the
Managed Care Environment Cardiovascular disease remains a leading killer in the United States, and epidemiologic studies continue to show a direct relationship between atherosclerosis and coronary heart disease (CHD). A quality improvement initiative revealed that patients with cardiac risk equivalents often are not being treated appropriately by clinicians; they are receiving less than optimal care. Recent clinical data released at the American Heart Association have stirred significant debate among cardiologists and other clinicians. As research improves our understanding of dyslipidemia, cardiac inflammation, endothelial dysfunction, and atherosclerosis, managed care professionals need continuing education that will help them implement appropriate strategies and prevention plans that will improve clinical outcomes in patients with cardiovascular disease. CME Valid to November 30, 2010 |
|
Evolution of Personalized Medicine:
The Role of Pharmacogenomics in Managed Care
The goal of this activity is to provide medical directors from plans, purchasers and provider systems and nurse case managers with appropriate education on personalized medicine and its impact on managed care environments. CME valid to November 10, 2010. |
The Relationship between Rheumatoid Arthritis and Heart Failure Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease affecting approximately 1% of the adult general population. Cardiovascular disease is recognized as the leading cause of death in RA patients, accounting for nearly 50 percent of their mortality. Patients with RA are at an increased risk for myocardial infarction, stroke, and heart failure. Some medications for RA may also worsen or precipitate heart failure. Optimal management of the RA patient requires attention to not only management of RA but also prevention of cardiovascular disease. CME valid to November 1, 2010. |
|
Management of an HIV Patient
Population Advances in treatment have changed AIDS into a chronically managed disease. Patients need to be identified early after initial HIV infection to prevent further spread of the infection and improve their life expectancy. Changes have been made to the health care setting recommendations for HIV screening to promote early and wide identification of HIV infections. CME valid to December 31, 2010 |
The Relationship and Impact of Diabetes and Cardiovascular Disease The prevalence of type 2 diabetes and obesity are both increasing. Because these are both major risk factors for the development of cardiovascular disease, the prevalence and mortality of cardiovascular disease is likely to increase. In order to prevent this, strategies for preventing diabetes, treating diabetes to accepted goals, and targeting associated CVD risk factors should be implemented. CME valid to December 31, 2010 |
|
Clinical and Financial Implications of Wound Care
Management
Across the Care Continuum |
Comparative Effectiveness:
The Impact on Managed Care and Patient Outcomes Although discussed and debated for several years, comparative effectiveness research is coming to the forefront as health care reform again becomes a federal government focus. There is significant debate ongoing about how to best fund, implement, and apply comparative effectiveness research. The recent economic stimulus bill has postponed some of the debate by providing a significant amount of money for this type of research. CME valid to August 31, 2010 |
|
Current Concepts in Managing Dyslipidemia The guidelines for managing dyslipidemia are continuing to evolve. Currently, very aggressive lowering of low density lipoprotein cholesterol is recommended for many patients. To achieve these aggressive goals, maximized statins or combination lipid lowering therapy is necessary. CME valid to August 31, 2010 |
Parkinson’s Disease: A How To Series This is a 4 part series on the Diagnosis, Treatment, Management and Future of Parkinson's Disease. With PD affecting at least 500,000 and costing over $6 billion annually, it is important to be appropriate educated on Parkinson's Disease and how to better manage this patient population. CME valid to July 31, 2010 |
|
Prevention, Diagnosis & Treatment of COPD COPD is a preventable and treatable disease that results in significant morbidity, mortality, and costs. Treatment uses a stepped care approach utilizing inhaled medications and non pharmacologic therapy. Smoking cessation, both on an individual and societal basis, is the most important factor in fighting COPD. CME valid to July 31, 2010 |
Schizophrenia: Improving
Outcomes While Managing Care Schizophrenia affects about 1% of Americans, which is well over two million adults. There is no cure. It is a chronic, severe brain disorder. Symptoms usually start in late teens to early 20s for men and mid 20s to early 30s for women CME valid to June 30, 2010 |
|
The Physical and Fiscal Impact of Sleep
Disorders Sleep disorders are common, result in significant health care costs, and have an important impact on patient functioning. The major sleep disorders are chronic insufficient sleep syndrome, obstructive sleep apnea, and insomnia. There are effective treatments for each. Managed care can easily implement interventions in several areas for both clinical and fiscal improvement in the treatment of sleep disorders. CME valid to June 30, 2010 |
|
|
|
|
